Clinical Trial: An Observational Study to Learn About Velsipity After Long Term Use in Patients With Ulcerative Colitis

U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT07459686) titled 'An Observational Study to Learn About Velsipity After Long Term Use in Patients With Ulcerative Colitis' on March 05.

Brief Summary: A study to assess the safety and effectiveness of Velsipity Tablets 2 mg during long-term treatment (up to a maximum of 52 weeks) in patients with ulcerative colitis under actual medical practice.

Study Start Date: March 31

Study Type: OBSERVATIONAL

Condition: Ulcerative Colitis (UC)

Intervention: DRUG: Velsipity

2 milligrams(mg) tablet as provided in real world practice

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Pfizer

Disclaimer: Curated by HT Syndication....